
Biotechnology
TYME stock is making solid gains this morning after the biotechnology company Tyme Technologies Inc (NASDAQ:TYME) announced encouraging data from its phase 2 study of SM-88. Solid News for Tyme Technologies The company released encouraging data ... [Read]